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Abstract 
Rabbit uterine cervical fibroblasts in culture produces tissue inhibitor of metalloproteinases (TIMP)-1 and TIMP-2. When cells were treated with 
physiological concentrations of progesterone, the production of two TIMPs increased, and essentially all TIMP-2 was found to be complexed with 
promatrix metalloproteinase 2 (proMMP_2)/progelatinase A. Progesterone did not modulate the production of proMMP-2 and resulted in the 
increased total amount of proMMP-2-TIMP-2 complex. These observations provide the first evidence that progesterone participates in maintaining 
the homeostasis of connective tissue matrix in uterine cervix by augmenting both TIMP-1 and TIMP-2 production along with the known suppressive 
effects on the proMMP-1 and proMMP-3 production. 
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1. Introduction 
Matrix metalloproteinases (MMPs) are a group of re- 
lated enzymes that participates in pathological and phys- 
iological breakdown of extracellular matrix components 
such as in arthritis, cancer cell invasion and metastasis, 
and cervical ripening and dilation at term pregnancy 
[l-6]. The activities of MMPs in the tissue are regulated 
by a number of factors, including gene expression of 
MMPs, extracellular activation of MMPs from their pre- 
cursors (proMMPs) and inhibition of MMPs by en- 
dogenous tissue inhibitors of metalloproteinases 
(TIMPs) [1,2]. In addition, the expression of TIMPs is 
shown to be regulated by a number of cytokines, 
hormones, transforming growth factor, and phorbol es- 
ters [7-91. Recent findings of specific complex formation 
between proMMP-2 (progelatinase A) and TIMP-2 [ 1 O- 
131, and between proMMP-9 (progelatinase B) and 
TIMP- 1 [ 14,151 have introduced additional complexity 
in regulation of extracellular matrix catabolism by 
MMPs. 
We have previously reported that in rabbit uterine 
cervical fibroblasts the production of TIMP-1 is up-reg- 
ulated by progesterone or oestradiol-17B whereas the 
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,466reviations: MMP, matrix metalloproteinase; TIMP, tissue inhibitor 
of metalloproteinases; MEM, Eagle’s minimum essential medium; 
LAH, lactalbumin hydrolysate; FBS, fetal bovine serum; PBS(-), cal- 
cium and magnesium-free phosphate-buffered saline; SDS-PAGE, so- 
dium dodecyl sulphate-polyacrylamide g l electrophoresis. 
production of proMMP-1 (interstitial procollagenase) 
and proMMP-3 (prostromelysin 1) is suppressed. These 
observations suggest that matrix catabolism in uterine 
cervix is down-regulated by these hormones [9]. The 
eventual catabolism of matrix, however, is dependent on 
the balance between the overall production of MMPs 
and TIMPs. In this regard, little is known about he 
regulation of TIMP-2 production, although it has been 
reported that TIMP-1 and TIMP-2 are differently regu- 
lated [ 16,171. Here, we report that progesterone nhances 
the production of TIMP-2 in rabbit uterine cervical fi- 
broblasts as well as TIMP- 1, resulted in accumulation of 
the proMMP-2-TIMP-2 complex in the medium of the 
progesterone-treated cells. The results suggest that pro- 
gesterone is a negative regulator of extracellular matrix 
degradation in uterine cervix. 
2. Materials and methods 
2.1. Materials 
The following reagents were obtained commercially: Eagle’s mini- 
mum essential medium (MEM) from Grand Island Biological Co., 
Grand Island, NY, USA, fetal-bovine serum (FBS) from Whittaker 
Bioproducts, Walkersville, MD, USA; progesterone, oestradiol-17/3, 
alkaline phosphatase-conjugated donkey anti-(sheep IgG) IgG and al- 
kaline-phosphatase conjugated goat anti-(rabbit IgG) IgG from Sigma 
Chemical Co., St. Louis, MO, USA; Gelatin-Sepharose 4B from Phar- 
macia LKB Biotechnology, Uppsala, Sweden. Human TIMP-2 was 
purified from the culture medium of human uterine cervical fibroblasts 
by chromatography on Gelatin-Sepharose as proMMP-2-TIMP-2 
complex and subsequent separation of the complex by SDS-PAGE 
under non-reducing condition. After SDS-PAGE, TIMP-2 was electro- 
eluted from the gel. Human TIMP-1 was also purified by the method 
of Morodomi et al. [18]. Sheep anti-(human TIMP-1) antiserum, sheep 
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anti-(human TIMP-2) antiserum and rabbit anti-(human proMMP-2) 
antiserum were prepared by injecting the purified antigens emulsified 
with complete Freund’s adjuvant and the subsequent boosters with 
incomplete Freund’s adjuvant as described previously [19]. Other rea- 
gents used were of analytical-reagent grade. 
2.2. Cell culture of rabbit uterine cervix 
Uterine cervical fibroblasts were established from Nippon white rab- 
bits of 23 days gestational age and maintained in culture in 1 .O ml of 
MEM/lO% (v/v) FBS in 24-multiwell plates as described previously 
[20]. In all experiments, cells at the first passage were used. To estimate 
production of proMMP-2, TIMP-1 and TIMP-2, the culture medium 
was changed to MEM/O.Z% (w/v) lactalbumin hydrolysate (LAH) after 
confluence, and progesterone and other reagents were added to the 
medium as an ethanol solution. The final ethanol concentration was 
0.1% (v/v) in all cultures, and the same amount of vehicle was added 
to the control cultures. The harvested culture media were stored at 
-20°C until use. 
2.3. Reverse gelatin zymography for TIMPs 
The sample was subjected to SDS-PAGE [21] using a 12.5% (w/v) 
acrylamide slab gel containing 0.6 mg/ml gelatin under non-reducing 
conditions. Then SDS in the gel was removed by rinsing with 50 mM 
Tris-HCl, 5 mM CaCl,, 1 PM ZnCl,, 0.02% NaN, (pH 7.5) containing 
2.5% (w/v) Triton X-100. The zel was then incubated in 20 ml of the 
same buffer without Triton X-100 and containing 5 units/ml of MMP-2 
for 20 h at 37°C. The gel was stained with 0.1% (w/v) Coomassie 
brilliant blue in 50% (v/v) methanol/20% (v/v) acetic acid, and destained 
with 1% (v/v) formic acid/30% (v/v) methanol. 
2.4. Western blotting for proMMP-2. TIMP-1 and TIMP-2 
Each sample from quadruplicate wells was mixed with l/5 volume of 
20% (w/v) trichloroacetic a id. The resultant precipitates were dissolved 
in reducing SDS-PAGE sample buffer 1211, and the portion was first 
subjected to SDS-PAGE using 10% (w/v) (for proMMP-2) and 12.5% 
(w/v) (for TIMP-1 and TIMP-2) acrvlamide slab eel under reducine 
I d 
conditions, and then proteins in gels were electro-transferred onto a 
nitrocellulose membrane. The membrane was reacted with sheep anti- 
(human TIMP-1 or TIMP-2) antiserum which was then complexed with 
alkaline phosphatase-conjugated donkey anti-(sheep IgG) IgG. Im- 
munoreactive TIMP-1 and TIMP-2 were visualized indirectly using 
5-bromo-4-chloro-3-indolyl phosphate and Nitroblue tetrazolium ai 
described previously [8]. ProMMP-2 was similarly detected using rabbit 
anti-(human proMMP-2) antiserum and alkaline phosphatase conju- 
gated goat anti-(rabbit IgG) IgG. 
2.5. Identification of the proMMP-2 complex with TIMP-2 
An aliquot of the culture media (1 .O ml) was mixed with 100 ,ul of 
50% (v/v) gelatin-Sepharose, and the mixture was incubated at room 
temperature for 45 min, and centrifuged at 11,750 x g for 10 min. The 
precipitates (gelatin-binding fraction) were washed twice with PBS(-), 
and then subjected to Western blotting for proMMP-2 and TIMP-2 as 
described above. The supernatant (gelatin-nonbinding fraction) was 
again treated with gelatin-Sepharose and centrifuged as above, and 
then the supematant was also subjected to Western blotting. 
3. Results and discussion 
3.1. Effect of progesterone on the production of TIMP-2 
in rabbit uterine cervical fibroblasts 
Reverse gelatin zymographic analysis of culture me- 
dium of rabbit uterine cervical fibroblasts exhibited two 
inhibitory bands at around 28 kDa and 20 kDa, and the 
molecular masses corresponding to those of human 
TIMP-1 and human TIMP-2, respectively (Fig. 1, lane 
1). The results indicate that rabbit uterine cervical fi- 
broblasts spontaneously produce and secrete TIMP-2 as 
well as TIMP-1. When the confluent cells were treated 
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Fig. 1. Reverse gelatin zymogram for TIMPs from rabbit uterine cervi- 
cal fibroblasts. Confluent rabbit uterine cervical fibroblasts were 
treated with various concentrations of progesterone in 1 .O ml of 0.2% 
(w/v) LAHlMEM for 48 h. An aliquot (10 ~1) of the culture media from 
quadruplicate wells was subjected to reverse gelatin zymography as 
described in the text. Three independent experiments werehighly repro- 
ducible and the typical data are shown. Lane 1, control; lanes 2-6, cells 
treated with progesterone at 1 x lo-“’ M, 1 x 10m9 M, 1 x 10m8 M, 
1 x 10e7 M and 1 x 10m6 M, respectively; lane 7, purified human TIMP-1 
(1 ng) and lane 8, purified human TIMP-2 (4 ng). 
with progesterone (1 x lo-” M to 1 x 10m6 M) for 48 h, 
the accumulation of TIMP-1 and TIMP-2 in the culture 
media increased in a dose-dependent manner (Fig. 1, 
lanes 2-6). This was also supported by Western blotting: 
maximum 2-fold increase was observed with 1 x 10m6 M
of progesterone as compared with the untreated control 
(Fig. 2A, lane 6). Progesterone augmented the produc- 
tion of TIMP-1 more effectively than that of TIMP-2: a 
maximum g-fold increase of the basal level was detected 
with 1 x 10m6 M progesterone (Fig. 2B, lane 6). On the 
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Fig. 2. Western blotting for TIMPs-1 and -2 in culture media of rabbit 
uterine cervical fibroblasts treated with progesterone. The harvested 
culture medium (1.2 ml) as described in Fig. 1 was concentrated and 
subjected to Western blotting for TIMP-1 and TIMP-2 as described in 
the text. The relative amounts of TIMP-1 and TIMP-2 were quantified 
by densitometric scanning, taking the control as 100%. Three independ- 
ent experiments were highly reproducible and the typical data are 
shown. Lane 1, control and lanes 2-6, cells treated with progesterone 
at 1 x lO_“’ M, 1 x IO+’ M, 1 x lo-’ M, 1 x lo-’ M and 1 x 10m6 M, 
respectively. Panel (A), TIMP-2 and panel (B), TIMP-1. 
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Fig. 3. Identification of the formation of proMMP-2 complex with 
TIMP-2 in rabbit uterine cervical fibroblasts. The harvested culture 
medium (1.0 ml) of rabbit uterine cervical fibroblasts treated with or 
without progesterone at 1 x 10e6 M as described in Fig. 1. was mixed 
with 100 ~1 of 50% (v/v) gelatin-Sepharose. ProMMP-2 and TIMP-2 
in gelatin-binding fraction and gelatin-nonbinding fraction were ana- 
lyzed by Western blotting as described in the text. Two independent 
experiments were highly reproducible and the typical data are shown. 
Panel (A), proMMP-2 and panel (B), TIMP-2. 
contrary, oestradiol-17/3 failed to increase the produc- 
tion of TIMP-2 although it increased the production of 
TIMP- 1, but to a lesser extent compared with progester- 
one (data not shown). 
3.2. Progesterone increased the complex of proMMP-2 
and TIMP-2 
It is of interest that TIMP-2 forms a complex with 
proMMP-2 through C-terminal domain of each mole- 
cule [lO-131. We, therefore, have examined whether the 
increased production of TIMP-2 by progesterone partic- 
ipated in the formation of the proMMP- 2-TIMP-2 com- 
plex by using gelatin-Sepharose. Most TIMP-2 found in 
the medium was recovered in the gelatin-binding fraction 
(Fig. 3B, lanes 14), and the distribution pattern of 
TIMP-2 was identical to that of proMMP-2 (Fig. 3A), 
indicating that most TIMP-2 in both media of the con- 
trol and the progesterone-treated cells was complexed 
with proMMP-2. 
Progesterone did not modulate the proMMP-2 pro- 
duction (Fig. 3A, lanes 14), whereas the amount of 
gelatin-Sepharose bound TIMP-2 increased in the pro- 
gesterone-treated cells. These results suggested that the 
TIMP-2 increased by progesterone plays a significant 
role in proMMP-2 activation, since a complex formation 
of proMMP-2 with TIMP-2 prevents the proMMP-2 
activation by p-aminophenylmercuric acetate (K. Imada, 
A. Ito, Y. Mori, Y. Itoh and H. Nagase, unpublished 
111 
data) or by the cell surface activator [22]. Recently, Mar- 
baix et al. [23] have reported that progesterone sup- 
presses the release of active MMP- 2 from human en- 
dometrial explants. Although the mechanism was not 
investigated by these workers, the decreased release of 
active MMP-2 may be resulted from the increased pro- 
duction by progesterone of TIMP-2. 
Uterine cervix is a typical connective tissue in which 
degradation of extracellular matrix occurs in a timely 
manner during cervical ripening and dilatation at term 
pregnancy. MMPs and TIMPs are considered to play a 
pivotal role in this process. In this regard, we previously 
reported that progesterone augmented the TIMP-1 pro- 
duction and effectively suppresses the MMPs production 
[9]. In this report, we have demonstrated that rabbit 
uterine cervical fibroblasts produce TIMP-2 in addition 
to TIMP-1, and that progesterone is a physiological 
stimulator of the production of both TIMP-1 and TIMP- 
2. 
In conclusion, we suggest that progesterone plays an 
important role in maintaining the function of uterine 
cervix during pregnancy by overall suppression of matrix 
degradation by increasing the production of TIMP-2 
which prevents the proMMP-2 activation along with the 
augmentation of TIMP-1 production and the suppres- 
sion of proMMP-1 and proMMP-3 production. 
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